Browse site A – Z

Your views

Your Views

Your feedback is vital to us as we continue to increase the quality of our services.

Your views

You are here:

Date: 30 June 2024

Time: 20:19

Image (from left to right):
Jane and Nick Flint (KPA), Mr Nick Inston (Consultant Renal Surgeon), Len and Joan Ingram (KPA)

QEHB kidney research benefits from charity

Story posted/last updated: 22 September 2014

A charity which supports kidney patients at the Queen Elizabeth Hospital Birmingham (QEHB) has donated £23,000 to fund a research project.

The Queen Elizabeth Hospital Kidney Patients' Association (KPA) has given the funding to Mr Nick Inston, Consultant Renal Surgeon, who is looking at new ways to access patients’ blood vessels for dialysis treatment. Mr Inston said:

“Kidney disease patients who are on dialysis require access to the blood vessels multiple times a week and this causes the vessels to scar and narrow. This research is looking at ways to improve the success and longevity of vascular access for patients.

“With the generous support of the KPA, the QEHB vascular access research group is leading research in this area. This current project is aimed at using a simple drug to open up the veins after surgery and increase the blood flow to enable more successful outcomes and better dialysis.”

Mr Inston added: “I’d like to thank the KPA supporters for their generosity. It’s a fantastic sum of money which will have a direct positive impact on renal patient care.”

Getting Here

Getting here

Information about travelling to, staying at and getting around the hospital.

Getting to the hospital

Jobs at UHB

Jobs at UHB

A great place to work. Learn why.

Jobs at UHB

news@UHB

news@UHB, the newsletter for patients, staff, visitors and volunteers at University Hospitals Birmingham NHS Foundation Trust

Read news@UHB

RSS

RSS feed

Subscribe to our news feed

View our RSS

We're improving the accessibility of our websites. If you can't access any content or if you would like to request information in another format, please view our accessibility statement.